Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Quinn

Showing results (171-180 of 206) with videos related to

Pageof 21
Sort By:
The Journal of Biological Chemistry|October 17, 2024
PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastomaNazia Nazam, Michael H Erwin, Janet R Julson, et al.
Obstetrics and Gynecology|September 17, 2015
Effectiveness of Labor Cervical Examination Simulation in Medical Student EducationJoshua F Nitsche, Kristina M Shumard, Nora F Fino, et al.
Cell Death & Disease|January 15, 2026
PP2A activation targets MYCN in neuroblastomaNazia Nazam, Shamza Manzoor, Maryam Shaikh, et al.
Journal of Pediatric Surgery|March 12, 2023
The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on HepatoblastomaLaura V Bownes, Janet R Julson, Colin H Quinn, et al.
Journal of Traumatic Stress|March 19, 2016
Treatment of Mental or Physical Health Problems in a Combat Zone: Comparisons of Postdeployment Mental Health and Early Separation From ServiceTerry L Conway, Emily A Schmied, Gerald E Larson, et al.
Scientific Reports|September 15, 2019
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived XenograftsLaura L Stafman, Adele P Williams, Raoud Marayati, et al.
Cancers|November 27, 2024
Novel PP2A-Activating Compounds in NeuroblastomaNazia Nazam, Laura V Bownes, Janet R Julson, et al.
Journal of Pediatric Surgery|March 18, 2022
Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotypeRaoud Marayati, Janet R Julson, Laura V Bownes, et al.
Translational Oncology|April 22, 2021
Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like TumorColin H Quinn, Andee M Beierle, Adele P Williams, et al.
Translational Oncology|July 3, 2024
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumorsColin H Quinn, Andee M Beierle, Adele P Williams, et al.
Pageof 21

Showing results (171-180 of 206) with videos related to

Sort By:
Pageof 21
The Journal of Biological Chemistry|October 17, 2024
PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastomaNazia Nazam, Michael H Erwin, Janet R Julson, et al.
Obstetrics and Gynecology|September 17, 2015
Effectiveness of Labor Cervical Examination Simulation in Medical Student EducationJoshua F Nitsche, Kristina M Shumard, Nora F Fino, et al.
Cell Death & Disease|January 15, 2026
PP2A activation targets MYCN in neuroblastomaNazia Nazam, Shamza Manzoor, Maryam Shaikh, et al.
Journal of Pediatric Surgery|March 12, 2023
The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on HepatoblastomaLaura V Bownes, Janet R Julson, Colin H Quinn, et al.
Journal of Traumatic Stress|March 19, 2016
Treatment of Mental or Physical Health Problems in a Combat Zone: Comparisons of Postdeployment Mental Health and Early Separation From ServiceTerry L Conway, Emily A Schmied, Gerald E Larson, et al.
Scientific Reports|September 15, 2019
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived XenograftsLaura L Stafman, Adele P Williams, Raoud Marayati, et al.
Cancers|November 27, 2024
Novel PP2A-Activating Compounds in NeuroblastomaNazia Nazam, Laura V Bownes, Janet R Julson, et al.
Journal of Pediatric Surgery|March 18, 2022
Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotypeRaoud Marayati, Janet R Julson, Laura V Bownes, et al.
Translational Oncology|April 22, 2021
Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like TumorColin H Quinn, Andee M Beierle, Adele P Williams, et al.
Translational Oncology|July 3, 2024
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumorsColin H Quinn, Andee M Beierle, Adele P Williams, et al.
Pageof 21